Kendall Capital Management Novartis Ag Transaction History

Kendall Capital Management

$316 Million
Q3 2024

A detailed history of Kendall Capital Management transactions in Novartis Ag stock. As of the latest transaction made, Kendall Capital Management holds 2,345 shares of NVS stock, worth $227,066. This represents 0.09% of its overall portfolio holdings.

Number of Shares

2,345

Previous 2,345 -0.0%

Holding current value

$227,066

Previous $249,000 8.03%

% of portfolio

0.09%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$92.57 - $107.37 $7,035 - $8,160	-76 Reduced 3.14%	2,345 $249,000
Q1 2024 May 10, 2024	BUY	$95.27 - $108.47 $4,858 - $5,531	51 Added 2.15%	2,421 $234,000
Q4 2023 Jan 26, 2024	SELL	$92.27 - $101.54 $9,227 - $10,154	-100 Reduced 4.05%	2,370 $239,000
Q2 2023 Jul 28, 2023	SELL	$92.52 - $104.91 $27,756 - $31,473	-300 Reduced 10.83%	2,470 $249,000
Q1 2023 May 11, 2023	SELL	$80.03 - $92.81 $3,681 - $4,269	-46 Reduced 1.63%	2,770 $255,000
Q4 2022 Jan 30, 2023	SELL	$75.55 - $92.52 $24,553 - $30,069	-325 Reduced 10.35%	2,816 $255,000
Q3 2022 Nov 02, 2022	SELL	$74.61 - $87.26 $11,340 - $13,263	-152 Reduced 4.62%	3,141 $239,000
Q2 2022 Jul 29, 2022	SELL	$80.52 - $93.75 $10,065 - $11,718	-125 Reduced 3.66%	3,293 $278,000
Q4 2021 Jan 28, 2022	SELL	$79.7 - $88.13 $717 - $793	-9 Reduced 0.26%	3,418 $299,000
Q3 2021 Nov 05, 2021	BUY	$81.78 - $95.14 $736 - $856	9 Added 0.26%	3,427 $280,000
Q2 2021 Jul 30, 2021	SELL	$85.24 - $94.15 $8,524 - $9,415	-100 Reduced 2.84%	3,418 $312,000
Q4 2020 Feb 08, 2021	BUY	$78.07 - $94.43 $12,491 - $15,108	160 Added 4.76%	3,518 $332,000
Q3 2020 Oct 22, 2020	SELL	$82.14 - $91.0 $51,337 - $56,875	-625 Reduced 15.69%	3,358 $292,000
Q2 2020 Jul 30, 2020	BUY	$80.93 - $91.1 $1,213 - $1,366	15 Added 0.38%	3,983 $348,000
Q1 2020 Apr 27, 2020	SELL	$70.67 - $99.01 $2,614 - $3,663	-37 Reduced 0.92%	3,968 $327,000
Q4 2019 Jan 24, 2020	SELL	$84.35 - $95.37 $6,326 - $7,152	-75 Reduced 1.84%	4,005 $379,000
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $4,277 - $4,713	-50 Reduced 1.21%	4,080 $355,000
Q2 2019 Aug 09, 2019	SELL	$75.4 - $92.8 $13,572 - $16,704	-180 Reduced 4.18%	4,130 $377,000
Q1 2019 May 08, 2019	SELL	$75.32 - $86.15 $11,297 - $12,922	-150 Reduced 3.36%	4,310 $414,000
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $22,098 - $24,606	-300 Reduced 6.3%	4,460 $383,000
Q3 2018 Oct 29, 2018	SELL	$66.94 - $77.43 $167,350 - $193,575	-2,500 Reduced 34.44%	4,760 $410,000
Q2 2018 Jul 27, 2018	SELL	$64.91 - $73.36 $11,359 - $12,838	-175 Reduced 2.35%	7,260 $548,000
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $122,830 - $146,841	1,745 Added 30.67%	7,435 $601,000
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $411,557 - $441,771	5,690	5,690 $478,000

Others Institutions Holding NVS

# of Institutions

1,438

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $208B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.

Account

Kendall Capital Management Novartis Ag Transaction History